Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning
(Q36583710)
scientific article published on 16 February 2016
scientific article published on 16 February 2016
Language:
Current Data About
Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning
other details
| description | scientific article published on 16 February 2016 |
External Links
| (P356) |
10.1186/S40425-016-0110-8
|
| (P698) |
26885368
|
| (P932) |
4754841
|
| (P6179) |
1004044355
|